Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Chemokine CXCR3 antagonists designed by Millennium and Kyowa Hakko

Nov. 27, 2002

Canadian approval for Thymoglobulin in renal transplant patients

Nov. 27, 2002

Japan Energy and Sumitomo describe new immunomodulators for cancer and other disorders

Nov. 26, 2002

Cannabinoid CB2 receptor modulators under study at Shionogi

Nov. 22, 2002

Cytos and Medarex collaborate for new drug targets in immunological diseases

Nov. 18, 2002

Myfortic receives first major approval in Switzerland

Nov. 8, 2002

Novel triptolide prodrugs and their use in cancer and autoimmune diseases

Nov. 8, 2002

LF-15-0195 induces long-term heart allograft survival in rat model

Nov. 4, 2002

Organ Recovery Systems cleared to market improved kidney perfusion solution

Nov. 4, 2002

Cell Therapeutics presents new inhibitors of IL-12 and IL-4 signaling for asthma, diabetes, etc.

Oct. 30, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...